WD-40 Company shares are up approximately 16% in premarket trading after a blowout fiscal third-quarter earnings report. The primary catalyst is a massive earnings and revenue beat, with adjusted EPS of $2.33 versus a consensus estimate of $1.58, a surprise of more than 47%.

Circle Internet Group shares are indicated up approximately 13% in premarket trading, rebounding sharply from recent weakness. The primary catalyst appears to be a broad crypto-sector rally, with Bitcoin up roughly 10% in July on improving rate-cut expectations.

Shares of Fermi Inc. are down roughly 16% in premarket trading following news of a $375 million convertible senior notes offering. The primary catalyst is dilution concern tied to the upsized convertible debt sale, which offers conversion protection only up to $14.64 per share.

Price Target: $1,500 per share, representing approximately 51% upside from current levels near $992, is a widely discussed analyst target backed by several major Wall Street firms. Strongest Bullish Factors: AI-driven demand for high-bandwidth memory (HBM) has created a structural supply shortage, with Micron's HBM capacity sold out through 2027 and $100 billion in multi-year strategic customer agreements providing unprecedented revenue visibility.

The $130 price target represents a meaningful upside from Walmart's recent trading range around $113, with multiple Wall Street analysts setting price targets at or above this level. Strong bullish factors include Walmart's expanding high-margin businesses such as advertising and membership income, robust e-commerce growth, and consistent market share gains across income brackets.

The $800 price target represents roughly 33% upside from recent trading levels near $603, and is widely discussed among Wall Street analysts. Exceptional advertising revenue growth, with a 26% year-over-year increase in the most recent quarter, powered by AI-driven ad targeting and rising user engagement, is the strongest bullish catalyst.

Price target in focus: $1,400 represents a widely discussed analyst target and a logical next milestone for Eli Lilly and Company (LLY) , implying roughly 15% upside from recent levels near $1,215. Strongest bullish factors: An industry-leading portfolio of GLP-1 drugs, a historic $27 billion manufacturing expansion, and expanding insurance coverage are creating a powerful revenue flywheel.

Price Target: $250 represents the lowest Wall Street analyst target and a potential new all-time high above the 52-week peak of $236.54. Bullish Catalysts: Record data center revenue of $75.2 billion in Q1 FY2027, Blackwell architecture ramp, and projected hyperscaler AI capex reaching $1 trillion by 2027.

Hyatt Hotels Corporation is scheduled to report second quarter 2026 results on July 30, 2026, before market open. Analyst consensus estimates call for diluted EPS of approximately $0.92 and revenue near $1.81 billion.

Delta Air Lines is set to report second-quarter 2026 results on July 10, 2026, before market open. Consensus estimates point to adjusted earnings per share of approximately $1.48 to $1.49.

PepsiCo reported net revenue of $24.18 billion for the second quarter, up 6.4% year over year and ahead of analyst expectations. Adjusted earnings per share came in at $2.20, slightly below the $2.21 consensus estimate but up 4% from the prior year on a core basis.

NOAH shares fell -12.78% during regular trading on Thursday, dropping from a prior close of $10.25 to $8.94, and hit a new 52-week low of $8.90 intraday. The primary driver is the stock trading ex-dividend for a substantial $1.3806 per share annual dividend, with the price decline closely matching the dividend amount.

AIIO shares tumbled -15.03% during regular market hours on July 9, falling to $3.365 from a previous close of $3.96, extending a brutal multi-week sell-off. The decline is driven by continued profit-taking and technical unwinding after the stock's parabolic AI-hype rally in May and June, with no new positive catalysts to stem the selling.

ENRD fell -15.21% during today's regular session, dropping from a previous close of $8.15 to $6.91, extending a multi-week downtrend. The primary catalyst is the July 7–8 SEC filing of an F-1 registration statement to register up to 103.96 million ADSs for resale by selling securityholders, representing approximately 51.2% of outstanding shares.

IONS shares plunged -23.51% during Thursday's regular session, extending a steep premarket selloff that began after the company announced a major clinical trial failure. The primary catalyst: the Phase 3 CARDIO-TTRansform trial of eplontersen (Wainua) in transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) failed to meet its primary efficacy endpoint of reducing cardiovascular mortality and recurrent cardiovascular events versus placebo through Week 140.

RXT plunged approximately -31.23% during regular trading on July 9, falling from a prior close of $6.58 to an intraday low near $4.53, on heavy volume roughly 1.7x the daily average. The primary catalyst was a sharp cut to FY2026 guidance: revenue reduced by $150M to $2.45B–$2.55B and Adjusted EBITDA trimmed by $20M to $285M–$295M, driven by exits from low-margin resale and colocation businesses.

PLBL shares plunged -18.14% in after-hours trading on Thursday, falling to $6.115 from a prior regular-session close of $7.47, extending a brutal two-day sell-off. The decline marks a continued unwinding of the speculative frenzy triggered by the company's July 2 announcement of a non-binding MOU to explore a 100 MW AI data center in Thailand.

MU surged +8.63% during regular market hours, climbing from yesterday's close of $948.80 to $1,030.72, reversing a sharp multi-day selloff that had pushed the stock into bear-market territory. The primary catalyst was a powerful memory-sector rebound triggered by Samsung's blowout preliminary Q2 results showing a 19-fold year-over-year profit surge, which reaffirmed that AI-driven memory demand remains robust.

Lam Research shares surged +9.94% during regular market hours on Thursday, rebounding sharply from the prior session's close of $333.15 to trade near $366.26, as the entire semiconductor sector staged a powerful recovery. The primary catalyst was a broad chip-stock rally fueled by reports that China may ease restrictions on advanced AI chip imports, potentially expanding demand for high-end semiconductor equipment.

BSP fell -5.35% during regular trading on July 9, sliding to $32.40 and extending its post-IPO decline for a seventh consecutive session below the $40.50 first-day close. The stock now sits just +11.7% above its $29 IPO price, as profit-taking continues to unwind the initial +39.7% debut surge from July 1.